Therapy monitoring with FDG-PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.

被引：0
|
作者：
Dimitrakopoulou-Strauss, A
Rudi, J
Strauss, LG
机构：
[1] Univ Heidelberg, Med Clin, Heidelberg, Germany
[2] German Canc Res Ctr, D-6900 Heidelberg, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
446
引用
收藏
页码：113P / 113P
页数：1
相关论文
共 50 条
  • [31] The Impact of FDG-PET for the Preoperative Management of Patients with Colorectal Cancer
    Kilbas, Zafer
    Yigit, Taner
    Ilgan, Seyfettin
    Arslan, Nuri
    Mentes, Oner
    Oner, Koksal
    Kozak, Orhan
    Tufan, Turgut
    BALKAN MEDICAL JOURNAL, 2011, 28 (02) : 133 - 137
  • [32] Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
    Christopher C. Riedl
    Katja Pinker
    Gary A. Ulaner
    Leonard T. Ong
    Pascal Baltzer
    Maxine S. Jochelson
    Heather L. McArthur
    Mithat Gönen
    Maura Dickler
    Wolfgang A. Weber
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1428 - 1437
  • [33] Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
    Riedl, Christopher C.
    Pinker, Katja
    Ulaner, Gary A.
    Ong, Leonard T.
    Baltzer, Pascal
    Jochelson, Maxine S.
    McArthur, Heather L.
    Gonen, Mithat
    Dickler, Maura
    Weber, Wolfgang A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1428 - 1437
  • [34] Evaluation of quality of life, satisfaction and cost of care in metastatic colorectal cancer patients receiving ambulatory chemotherapy.
    Chansriwong, Phichai
    Sirilerttrakul, Suwannee
    Wannakansophon, Nopakan
    Tangteerakoon, Patamaporn
    Vongterapak, Suluck
    Jirajarus, Manmana
    Ckumdee, Sineenuch
    Sirachainan, Ekaphop
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] Chemotherapy response monitoring in colorectal liver metastases by DCE-MRI and FDG-PET
    Vriens, Dennis
    van Laarhoven, Hanneke
    van Asten, Jack
    Krabbe, Paul
    Visser, Eric
    Heerschap, Arend
    Punt, Cornelis
    de Geus-Oei, Lioe-Fee
    Oyen, Wim
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [36] Symptom burden among metastatic cancer patients receiving palliative chemotherapy.
    Cristal Luna, Herdee Gloriane
    Enrique Montoya, Jose
    Morelos, Amherstia
    Roberto Amparo, Jose
    Marbella, Leo
    Lesaca, Reynaldo
    Cristal-Luna, Gloria R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Detection of recurrence of colorectal cancer by FDG-PET
    Ike, H
    Saito, S
    Yamagishi, S
    Fujii, S
    Ichikawa, Y
    DISEASES OF THE COLON & RECTUM, 2004, 47 (06) : 1015 - 1015
  • [38] The role of FDG-PET CT in colorectal cancer
    Jafferbhoy, S.
    Chambers, A.
    Mander, J.
    Paterson, H.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 88 - 88
  • [39] Monitoring liver resection for metastatic colorectal cancer with FDG-PET.
    Oyen, WJ
    Langenhoff, BS
    Ruers, TJ
    Jager, GJ
    Corstens, FH
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 308P - 308P
  • [40] Predictive value of ERCC1 and KRAS in colorectal cancer patients with FOLFOX chemotherapy.
    Lee, In Kyu
    Choi, Sung-Bong
    Cheung, DaeYoung
    Kim, Jin Il
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
12345